Anirudh Sattiraju, PhD
Anirudh Sattiraju (Preferred Name)
img_Anirudh Sattiraju
INSTRUCTOR | Neuroscience
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]
Hypoxia status increases malignancy by equipping glioblastoma cells with stress-coping mechanisms to survive therapy and spawn recurrent tumor. Dr. Sattiraju’s recent work showed that hypoxic glioblastoma cells upregulate genes involved in immunosuppression in their niche. It is crucial to understand if glioblastoma cells conditioned by tumor hypoxia retain their transcriptional state during tumor progression and recurrence. Dr. Sattiraju tests the hypothesis that hypoxia exposed GBM cell lineages retain advantageous cellular states by employing a hypoxia induced lineage tracing system that can fate map lineages of hypoxic glioblastoma cells, in conjunction with single cell RNA sequencing.

BS, Amity University

MS, Wake Forest University

PhD, Wake Forest University

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Sattiraju has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.